drugset / Trial / NCT00240604

Prevention of Corticosteroid-induced Glucose Intolerance

NCT00240604

Phase 3 Unknown 100 enrolled Hadassah Medical Organization
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.

Timeline

Start
2005-04
Primary completion
2013-12
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg

Indications